<code id='2EA8A45B60'></code><style id='2EA8A45B60'></style>
    • <acronym id='2EA8A45B60'></acronym>
      <center id='2EA8A45B60'><center id='2EA8A45B60'><tfoot id='2EA8A45B60'></tfoot></center><abbr id='2EA8A45B60'><dir id='2EA8A45B60'><tfoot id='2EA8A45B60'></tfoot><noframes id='2EA8A45B60'>

    • <optgroup id='2EA8A45B60'><strike id='2EA8A45B60'><sup id='2EA8A45B60'></sup></strike><code id='2EA8A45B60'></code></optgroup>
        1. <b id='2EA8A45B60'><label id='2EA8A45B60'><select id='2EA8A45B60'><dt id='2EA8A45B60'><span id='2EA8A45B60'></span></dt></select></label></b><u id='2EA8A45B60'></u>
          <i id='2EA8A45B60'><strike id='2EA8A45B60'><tt id='2EA8A45B60'><pre id='2EA8A45B60'></pre></tt></strike></i>

          fashion

          fashion

          author:entertainment    Page View:1323
          Grail

          Three sales executives, all of them women, have filed suit against Grail, a cancer diagnostics company, alleging that they were harassed, that the company failed to take corrective action, and that it retaliated by removing them from consideration for promotions.

          The suits, which were filed earlier this week, are complicated by the fact that Grail was purchased by Illumina, the largest DNA sequencing firm, for $8 billion in 2021 — yet Illumina has left Grail to operate as a separate company. Illumina is named in the suit.

          advertisement

          All three plaintiffs are being represented by the Vora Law Firm, based in Santa Monica, Calif.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Sanofi strikes deal with Novavax, boosting the vaccine maker
          Sanofi strikes deal with Novavax, boosting the vaccine maker

          NICOLASMAETERLINCK/BELGAMAG/AFPviaGettyImagesLONDON—Novavax,thebeleagueredmakerofaCovid-19vaccine,ju

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Shionogi licenses Pompe disease therapy from Maze Therapeutics

          MazeTherapeuticsCEOJasonColomaCourtesyAfterseeingitslastdealgobustinthefaceofregulatoryscrutiny,Maze